1. Home
  2. NVNI vs NRXP Comparison

NVNI vs NRXP Comparison

Compare NVNI & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nvni Group Limited

NVNI

Nvni Group Limited

N/A

Current Price

$1.04

Market Cap

12.3M

Sector

N/A

ML Signal

N/A

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

HOLD

Current Price

$3.49

Market Cap

153.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVNI
NRXP
Founded
2019
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
153.2M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
NVNI
NRXP
Price
$1.04
$3.49
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$38.25
AVG Volume (30 Days)
28.4K
1.2M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.70
EPS
N/A
N/A
Revenue
N/A
$1,225,000.00
Revenue This Year
$6.67
$2,547.84
Revenue Next Year
$26.67
$1,591.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$1.65
52 Week High
$4.94
$5.06

Technical Indicators

Market Signals
Indicator
NVNI
NRXP
Relative Strength Index (RSI) 47.66 50.05
Support Level $0.96 $3.45
Resistance Level $1.15 $3.67
Average True Range (ATR) 0.08 0.30
MACD -0.00 0.05
Stochastic Oscillator 32.39 49.61

Price Performance

Historical Comparison
NVNI
NRXP

About NVNI Nvni Group Limited

Nvni Group Ltd, through its existing subsidiary companies, operates business-to-business software-as-a-service (B2B SaaS) products in Brazil, serving a diversified customer base of small and mid-sized enterprises across vertical markets. The Group's core business activity is providing a SaaS platform model focused on the software delivery method of cloud-based software applications to its customers. The Group generates revenues and profits from SaaS platform subscription services, data analytics services, set-up and other services. The Group has a single operating and reportable segment, multi-vertical SaaS solution model. The Group operates and generates revenue from Brazil.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: